Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer

Despite all treatment advances, lung cancer is still the main cause of death worldwide. [1] Approximately 30% of Non-Small Cell Lung Cancer (NSCLC) patients are diagnosed with locally advanced disease. Treatment for resectable stage IIIA remains controversial. [2,3] Guidelines recommendations include definitive chemoradiotherapy, induction chemotherapy followed by surgery, and induction chemoradiotherapy followed by surgical resection. [4,5]

Source: Lung Cancer - May 12, 2019 Category: Cancer & Oncology Authors: Laura Romero-Vielva, Santiago Viteri, Irene Moya-Horno, Jos é Ignacio Toscas, José Antonio Maestre-Alcácer, Santiago Ramón y Cajal, Rafael Rosell Source Type: research